NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/08/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization425.16 mln
Float17.90 mln
Earnings Date07/31/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.33
Borderline
1-Year Forecast
18.50
Attractive
Relative Strength
22
/ 100
Significantly lagging
Debt / Equity
0.01
Debt-free
ROE
-5.39
Negative
Business Description
Fulgent Genetics is a California-based healthcare company that offers a broad range of genetic and diagnostic testing services to patients, physicians, hospitals, and insurers across the United States and beyond. Their testing capabilities cover areas such as cancer screening, reproductive health, and tissue pathology, supported by proprietary software that helps identify meaningful health markers in a person's DNA. The company also develops cancer treatments using a specialized drug delivery platform designed to make therapies more effective and better tolerated by patients.
